Bloomage released its mid-year financial report, reporting a revenue of RMB 2.811 billion (~USD 385 million) for the first half of the year. This success reflects the company's strategic transformation from a traditional raw materials supplier to a solution provider, which has driven significant growth across its raw materials and medical terminal products businesses.
Hamamatsu Photonics K.K. (Hamamatsu City, Japan) has developed a new instrument, creating a unique class of cell analyzers. By implementing light-sheet optics and image analysis, in combination with an easy-to-use interface, we have engineered a fast, user-friendly system ideal for 3D cell screening assays.
Invensify, Inc. (Invensify), a global provider of innovative, energy-efficient cold chain shipping solutions, and Senpex, a provider of nationwide last-mile delivery services, today announced a partnership to enhance the delivery of temperature-sensitive pharmaceuticals. Through this collaboration, Senpex will incorporate Invensify's Insuridge™ shipping container into their logistics operations.
Alessandra Vignola has joined Worldwide Clinical Trials a global full-service contract research organization (CRO), as President of the Cardiovascular & Metabolic Business Unit. Vignola brings more than 30 years of extensive experience in the pharmaceutical and clinical research industry, enhancing the company's leadership in these critical therapeutic areas.
PHC Corporation Biomedical Division will showcase a prototype of its new cell expansion system LiCellGrow at the ISCT Regional Meeting. LiCellGrow, currently under development, is designed to allow pharmaceutical companies to visualize continuous metabolic changes in cells in real-time and adjust the cell culture automatically to optimize conditions for cell growth. The system seeks to expand availability of cell and gene therapy (CGT) products by accelerating the manufacturing of specific cells needed for these therapies.
QuidelOrtho Corporation has received U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its VITROS syphilis assay as part of its menu, strengthening QuidelOrtho’s position as a leader in infectious disease testing. Using the automated VITROS systems, this assay is intended for the qualitative determination of total (IgG and IgM) antibodies to Treponema pallidum (TP)-specific antigens in human serum and plasma using the automated VITROS 3600, 5600 and XT 7600 systems.
CytoTronics, Inc., a pioneer of semiconductor-based platforms for discovery in cell biology, introduced its high-throughput Pixel™ Octo system at the International Society for Stem Cell Research (ISSCR 2024) in Hamburg, Germany.
Cosette Pharmaceuticals, Inc. (“Cosette”), a US-based specialty pharmaceutical company, has completed the acquisition of Ambien® and Ambien CR® in the United States from Sanofi US.
C2N Diagnostics, LLC (“C2N”), which provides exceptional clinical laboratory services and advanced diagnostic solutions in the field of brain health, has entered into a non-exclusive agreement with Mayo Clinic Laboratories, for inclusion of C2N’s Precivity tests in Mayo Clinic Laboratories’ test offerings to its clients.
Merck, a leading science and technology company, and The Michael J. Fox Foundation for Parkinson's Research (MJFF), are advancing research aimed at slowing progression of Parkinson’s disease (PD).